Parc Sanitari Sant Joan De Deu
- Address
- lock Available on a paid plan
Psychiatry and Psychology
At Parc Sanitari Sant Joan De Deu, the psychiatry service is running studies focused on mental disorders, especially treatment-resistant depression. These trials are designed to explore new options for people whose symptoms have not improved with standard care and to better understand how to relieve depressive symptoms.
- Testing new therapeutic approaches for treatment-resistant depression
- Evaluating whether novel interventions can improve mood symptoms
- Supporting research into more effective care for difficult-to-treat depression
The site is contributing to research that may expand treatment choices in psychiatric care and improve outcomes for patients with persistent depression.
Cardiovascular Diseases
Clinical research in cardiovascular disease includes studies on acute pulmonary embolism, with a focus on improving patient recovery and reducing complications after diagnosis. These trials aim to assess whether supportive treatment strategies can make a meaningful difference in short-term outcomes.
- Studying acute pulmonary embolism management
- Assessing ways to improve recovery and reduce risk
- Evaluating treatment effectiveness in urgent cardiovascular care
This work helps clarify the best supportive approaches for patients facing serious blood-clot-related conditions.
Respiratory Tract Diseases
Research in respiratory diseases at this site covers chronic obstructive pulmonary disease and non-cystic fibrosis bronchiectasis. The studies are aimed at understanding long-term safety, symptom control, and the reduction of flare-ups in people living with chronic lung conditions.
- Evaluating new approaches for COPD
- Studying ways to reduce respiratory exacerbations
- Improving care for bronchiectasis and chronic breathing problems
These trials support better management of ongoing lung disease and may help identify treatments that improve daily breathing and overall stability.
Virus Diseases
The site is also active in virus disease research, with studies in HIV and HIV infections. These trials focus on maintaining viral suppression in people already receiving treatment and on testing new antiviral options for those starting therapy.
- Evaluating treatment strategies for HIV
- Assessing whether viral control can be maintained with different regimens
- Exploring new antiviral therapies for people living with HIV-1
This area of research aims to improve long-term infection control and expand options for people affected by HIV.
Immune System Diseases
In immune system disease research, the site is studying allergic rhinoconjunctivitis linked to common dust mite allergens. The trials are designed to evaluate whether targeted treatment can reduce allergy symptoms and improve comfort in people with persistent allergic disease.
- Studying allergic rhinoconjunctivitis and related symptoms
- Testing treatments for dust mite-driven allergy
- Improving symptom relief in allergic disease
These studies may help refine care for patients with ongoing allergy symptoms, including those who also have controlled asthma.
Bacterial Infections and Mycoses
Research in bacterial infections at Parc Sanitari Sant Joan De Deu includes work aimed at preventing infection-related complications in people undergoing total joint replacement. The purpose is to evaluate strategies that may lower the chance of reoperation linked to infection.
- Studying infection prevention in joint replacement surgery
- Evaluating methods to reduce postoperative infection risk
- Improving outcomes after hip and knee surgery
This research focuses on safer surgical recovery and better protection against serious infection-related problems.
Musculoskeletal Diseases
The site’s musculoskeletal disease research is centered on patients undergoing total joint replacement, including primary and revision procedures. These trials examine ways to improve surgical outcomes by reducing infection-related complications after major orthopedic surgery.
- Investigating recovery after hip and knee replacement
- Studying infection-related outcomes in orthopedic surgery
- Supporting safer care in revision joint replacement
The goal is to help patients recover more safely and with fewer complications after joint surgery.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 7 therapeutic areas and 15 of 25 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 5 by active trials.
- 1CSL Behring LLC1active
lock +4 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 567 other sites in Spain
Therapeutic Area Benchmark — Spain
Select a therapeutic area to compare against other sites in Spain.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Spain
Market Share
Country: Spain
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Parc Sanitari Sant Joan De Deu
lock Showing 1 of 10 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A multicenter, double-blind, placebo-controlled, clinical trial to evaluate the efficacy and safety of two concentrations of a mixture of depigmented polymerized allergenic extracts of D. pteronyssinus and D. farinae, in patients suffering from allergic rhinoconjunctivitis with or without controlled asthma | LETI Pharma S.L.U. | Phase III | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 25 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Dolutegravir Sodium | 2 | Unknown | 2021-06-22 | 2026-02-11 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.
